United Arab Emirates: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in the United Arab Emirates

In 2022, the market for other medicaments for therapeutic or prophylactic uses in the United Arab Emirates decreased by X% to $X, falling for the second consecutive year after two years of growth. Overall, consumption, however, continues to indicate prominent growth. Over the period under review, the market reached the maximum level at $X in 2020; however, from 2021 to 2022, consumption remained at a lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in the United Arab Emirates

In value terms, production of other medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2022 estimated in export price. Over the period under review, production saw a prominent increase. The most prominent rate of growth was recorded in 2020 when the production volume increased by X% against the previous year. As a result, production reached the peak level of $X. From 2021 to 2022, production of growth remained at a somewhat lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from the United Arab Emirates

In 2022, exports of other medicaments for therapeutic or prophylactic uses from the United Arab Emirates declined to X tons, waning by X% against 2021. Over the period under review, exports, however, continue to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2014 when exports increased by X%. As a result, the exports reached the peak of X tons. From 2015 to 2022, the growth of the exports of remained at a lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses reduced to $X in 2022. In general, total exports indicated a mild increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2020 indices. The most prominent rate of growth was recorded in 2013 when exports increased by X% against the previous year. Over the period under review, the exports of attained the peak figure at $X in 2017; however, from 2018 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Jordan (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from the United Arab Emirates, accounting for a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Jordan exceeded the volume sent to the second major destination, the United States (X tons), sevenfold. The third position in this ranking was taken by Algeria (X tons), with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to Jordan stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (X% per year) and Algeria (X% per year).

In value terms, Jordan ($X) remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from the United Arab Emirates, comprising X% of total exports. The second position in the ranking was held by Algeria ($X), with a X% share of total exports. It was followed by the United States, with a X% share.

From 2012 to 2022, the average annual growth rate of value to Jordan totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Algeria (X% per year) and the United States (X% per year).

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, waning by X% against the previous year. Over the period under review, the export price, however, saw a relatively flat trend pattern. The pace of growth appeared the most rapid in 2017 an increase of X% against the previous year. The export price peaked at $X per ton in 2019; however, from 2020 to 2022, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Saudi Arabia ($X per ton), while the average price for exports to Bahrain ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Saudi Arabia (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into the United Arab Emirates

In 2022, approx. X tons of other medicaments for therapeutic or prophylactic uses were imported into the United Arab Emirates; which is down by X% on the previous year. Overall, imports showed a pronounced slump. The pace of growth was the most pronounced in 2021 with an increase of X%. Imports peaked at X tons in 2015; however, from 2016 to 2022, imports failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses fell notably to $X in 2022. In general, imports, however, saw a moderate increase. The pace of growth was the most pronounced in 2015 when imports increased by X% against the previous year. As a result, imports reached the peak of $X. From 2016 to 2022, the growth of imports of remained at a somewhat lower figure.

Imports by Country

India (X tons), Germany (X tons) and Cyprus (X tons) were the main suppliers of imports of other medicaments for therapeutic or prophylactic uses to the United Arab Emirates, with a combined X% share of total imports.

From 2012 to 2022, the biggest increases were recorded for Germany (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X), Cyprus ($X) and India ($X) constituted the largest other medicaments for therapeutic or prophylactic uses suppliers to the United Arab Emirates, with a combined X% share of total imports.

Germany, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, growing by X% against the previous year. Over the period under review, import price indicated buoyant growth from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, import price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Saudi Arabia ($X per ton), while the price for China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :